Literature DB >> 24411468

Effects of different scaffolds on rat adipose tissue derived stroma cells.

Yahya Açil1, Xiacong Zhang1, Tobias Nitsche1, Björn Möller1, Volker Gassling1, Jörg Wiltfang1, Matthias Gierloff2.   

Abstract

BACKGROUND: Adipose tissue derived stroma cells (ASC's) offer for many advantages for tissue engineering strategies over mesenchymal stroma cells from other sources and ideal carrier materials have to be identified for them. The aim of this study was to demonstrate and to compare the effects of three clinically established biomaterials on proliferation and metabolic activity of rat ASC's in vitro.
MATERIALS AND METHODS: Rat adipose tissue derived stroma cells (ASC's) were isolated and differentiated into distinct lineages proved by lineage specific staining and gene expression analysis (RT-PCR). The biomaterials Bio-Gide(®), Tutodent(®) Membrane and Belotero(®) Soft were tested with rat ASC's for their biocompatibility using scanning electron microscopy (SEM), cell vitality staining, cytotoxicity and proliferation tests (LDH, MTT, BrdU, WST-1).
RESULTS: The collagen membrane Bio-Gide(®) resulted in a significantly higher viability and proliferation (WST-1, BrdU) compared to Tutodent(®) Membrane. No significant difference was determined in the LDH and MTT test. The hyaluronic acid gel Belotero(®) Soft showed no cytotoxicity (LDH, FDA/PI) and had no negative effects on metabolic activity (WST-1, MTT) or cell proliferation (BrdU) of ASC's.
CONCLUSION: Our results indicate Bio-Gide(®) and Belotero(®) Soft as preferable carrier materials for ASC's. For the further establishment of ASC's-based treatment strategies, in vivo investigations on the tissue regeneration potential of these cell-biomaterial scaffolds should follow.
Copyright © 2013 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adipose tissue derived stroma cells (ASC's); Biocompatibility; Collagen membranes; Hyaluronic acid gel; Multilineage potential; Scaffold; Tissue engineering

Mesh:

Substances:

Year:  2013        PMID: 24411468     DOI: 10.1016/j.jcms.2013.11.020

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  6 in total

1.  Therapeutic Potential of Adipose-Derived SSEA-3-Positive Muse Cells for Treating Diabetic Skin Ulcers.

Authors:  Kahori Kinoshita; Shinichiro Kuno; Hisako Ishimine; Noriyuki Aoi; Kazuhide Mineda; Harunosuke Kato; Kentaro Doi; Koji Kanayama; Jingwei Feng; Takanobu Mashiko; Akira Kurisaki; Kotaro Yoshimura
Journal:  Stem Cells Transl Med       Date:  2015-01-05       Impact factor: 6.940

Review 2.  Advances in Barrier Membranes for Guided Bone Regeneration Techniques.

Authors:  Ze Yang; Chang Wu; Huixin Shi; Xinyu Luo; Hui Sun; Qiang Wang; Dan Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-06-22

3.  Drilling Combined with Adipose-derived Stem Cells and Bone Morphogenetic Protein-2 to Treat Femoral Head Epiphyseal Necrosis in Juvenile Rabbits.

Authors:  Zi-Li Wang; Rong-Zhen He; Bin Tu; Jin-Shen He; Xu Cao; Han-Song Xia; Hong-Liang Ba; Song Wu; Cheng Peng; Kun Xiong
Journal:  Curr Med Sci       Date:  2018-04-30

4.  Muscone Promotes The Adipogenic Differentiation Of Human Gingival Mesenchymal Stem Cells By Inhibiting The Wnt/β-Catenin Signaling Pathway.

Authors:  Wen-Xiu Yuan; Xu-Xia Wang; De-Hua Zheng; Dan Ma; Qun Cui; Fan Yang; Jun Zhang
Journal:  Drug Des Devel Ther       Date:  2019-09-18       Impact factor: 4.162

Review 5.  Development of Synthetic and Natural Materials for Tissue Engineering Applications Using Adipose Stem Cells.

Authors:  Yunfan He; Feng Lu
Journal:  Stem Cells Int       Date:  2016-02-10       Impact factor: 5.443

6.  Evaluation of different commercial hyaluronic acids as a vehicle for injection of human adipose-derived mesenchymal stem cells.

Authors:  Camila Cohen Kaleka; Eder Zucconi; Tierri da Silva Vieira; Mariane Secco; Mário Ferretti; Moisés Cohen
Journal:  Rev Bras Ortop       Date:  2018-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.